ライフサイエンスコーパス: trichomoniasis

1 results from sexually transmitted infection (trichomoniasis).

2 nfirmed by Gram stain with no candidiasis or trichomoniasis).

3 (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis.

4 iterate women experience lower likelihood of trichomoniasis.

5 tiate novel insight into the epidemiology of trichomoniasis.

6 ts were tested for chlamydia, gonorrhea, and trichomoniasis.

7 screened with pooled sera from patients with trichomoniasis.

8 al sexually transmitted infection in humans, trichomoniasis.

9 harge, candidiasis, bacterial vaginosis, and trichomoniasis.

10 ibuting to tissue damage and inflammation in trichomoniasis.

11 may play a role in the pathogenesis of human trichomoniasis.

12 ications for treatment of NGU and control of trichomoniasis.

13 etronidazole reductively in the treatment of trichomoniasis.

14 rasitic protozoan and the causative agent of trichomoniasis.

15 an's risk of acquiring HIV-1, gonorrhea, and trichomoniasis.

16 ected vaginal specimens for the diagnosis of trichomoniasis.

17 BV but do not protect against VVC or vaginal trichomoniasis.

18 al candidiasis (VVC), and 7 acquired vaginal trichomoniasis.

19 ), bacterial vaginosis (2 studies; n = 930), trichomoniasis (1 study; n = 779), and genital herpes (1

20 8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9.3%] vs 261/1815 [14.4%]; rat

21 hlamydia, 18%; HSV-2, 4%; gonorrhea, 4%; and trichomoniasis, 3%.

22 ex virus type 2 (HSV-2), 14%; gonorrhea, 6%; trichomoniasis, 3%; and hepatitis B, 2%.

23 an anaerobic protozoan parasite that causes trichomoniasis, a common sexually transmitted disease wi

24 serious veterinary pathogen, causing bovine trichomoniasis, a sexually transmitted disease leading t

25 ital ulcer disease, bacterial vaginosis, and trichomoniasis among female partners.

26 sease, we recruited 521 female patients with trichomoniasis and 176 control subjects.

27 ccasional partner; and, in females, incident trichomoniasis and bacterial vaginosis.

28 findings suggest novel approaches to control trichomoniasis and warrant further studies of galectin-b

29 iasis, trichomoniasis vaginalis (hereafter, "trichomoniasis"), and colonization with Lactobacillus or

30 ns (15 gonorrhea, 10 chlamydial infection, 3 trichomoniasis), and 4 had dual infections.

31 stic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes was performed in a hi

32 nucleic acid amplification tests (NAATs) for trichomoniasis are accurate, quick and confirmative with

33 The true prevalence and clinical impact of trichomoniasis are unknown, as current methods of detect

34 Sexually transmitted diseases, including trichomoniasis, are risk factors for acquisition of huma

35 es along with the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.

36 pregnant women, the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chl

37 mpiric therapy for gonorrhea, chlamydia, and trichomoniasis based on updated treatment regimens; vacc

38 We screened pregnant women for trichomoniasis by culture of vaginal secretions.

39 imed to provide a more reliable diagnosis of trichomoniasis by investigating an association with leuk

40 Usually, trichomoniasis can be cured with single-dose therapy of

41 In females, trichomoniasis causes vaginitis, while in males, it is f

42 , 20%; specificity, 98%; PPV, 88%; NPV, 57%; trichomoniasis, colpitis macularis: sensitivity, 2%; spe

43 reatment of pregnant women with asymptomatic trichomoniasis does not prevent preterm delivery.

44 to wet mount for point-of-care diagnosis of trichomoniasis, especially in settings where microscopy

45 andidiasis (HR, 0.84; 95% CI, 0.67-1.04) and trichomoniasis (HR, 0.55; 95% CI, 0.27-1.12) among treat

46 ection in male sexual partners of women with trichomoniasis identified by wet mount and culture.

47 These included trichomoniasis in 16 women (11%); syphilis, 9 (6%); geni

48 o returned for at least one follow-up visit: trichomoniasis in 23 (18%); genital herpes, 20 (12%); go

49 bic flagellated protozoan, causes urogenital trichomoniasis in cattle.

50 is known about the epidemiologic profile of trichomoniasis in men and its relationship to human immu

51 Variations in estimates of prevalence of trichomoniasis in men may reflect true differences in th

52 uncertain whether treatment of asymptomatic trichomoniasis in pregnant women reduces the occurrence

53 oor sensitivity but is used for diagnosis of trichomoniasis in resource-poor settings.

54 The prevalence of trichomoniasis in the population was 16.7% (502 of 3,009

55 ted for chlamydial infection, gonorrhea, and trichomoniasis in wave 3 (2001-2002) of the National Lon

56 Vaginal lactobacilli may be associated with trichomoniasis in women with higher levels of education

57 PCR-ELISA may be useful for the detection of trichomoniasis in women.

58 effects of human immunodeficiency virus and trichomoniasis, in Lilongwe, Malawi.

59 omonas foetus, the causative agent of bovine trichomoniasis) induced a selective upregulation of chem

60 Trichomoniasis is a common sexually transmitted disease

61 Bovine trichomoniasis is a sexually transmitted disease caused

62 Trichomoniasis is a sexually transmitted infection that

63 Trichomoniasis is a significant sexually transmitted dis

64 lly transmitted infections (STIs) in Malawi, trichomoniasis is not considered for first-line treatmen

65 The effect that vaginal lactobacilli have on trichomoniasis is not known.

66 Trichomoniasis is the most common non-viral sexually tra

67 nas vaginalis, the causative agent for human trichomoniasis, is a problematic sexually transmitted di

68 of vaginal lactobacilli were associated with trichomoniasis (odds ratio [OR], 2.2 [95% confidence int

69 Trichomoniasis prevalence was inversely related to serum

70 ater likelihood of cervical inflammation and trichomoniasis relative to women in remote villages; wom

71 t in Spanish are also more likely to present trichomoniasis relative to women with moderate or no flu

72 Between randomization and follow-up, trichomoniasis resolved in 249 of 269 women for whom fol

73 ated protozoan, is the agent responsible for trichomoniasis, the most common nonviral sexually transm

74 andidiasis, bacterial vaginosis, and vaginal trichomoniasis using some combination of physical examin

75 cterial vaginosis (BV), vaginal candidiasis, trichomoniasis vaginalis (hereafter, "trichomoniasis"),

76 Trichomoniasis vaginalis is the most common nonviral sex

77 Trichomoniasis vaginalis, the most prevalent nonviral se

78 Trichomoniasis was associated only with having a new sex

79 Trichomoniasis was associated with a 1.52-fold (95% conf

80 ected vaginal specimens for the diagnosis of trichomoniasis was conducted.

81 nts with gonorrhea, chlamydial infection, or trichomoniasis were compared with specimens from 32 clin

82 TI clinic, urethral symptoms attributable to trichomoniasis were more severe among HIV-positive men t

83 andomly assigned 617 women with asymptomatic trichomoniasis who were 16 to 23 weeks pregnant to recei

84 ntribute to the epidemiologic association of trichomoniasis with the sexual transmission of HIV-1.